Journal of Ophthalmic and Vision Research

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 12  |  Issue : 1  |  Page : 11--16

Comparison of loteprednol with fluorometholone after myopic photorefractive keratectomy


Farid Karimian1, Amir Faramarzi1, Sahba Fekri1, Hossein Mohammad-Rabie2, Danial Najdi4, Azadeh Doozandeh2, Siamak Delfaza-Baher2, Mehdi Yaseri3 
1 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences; Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences; Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Sahba Fekri
Department of Ophthalmology, Labbafinejad Medical Center, Boostan 9 St., Pasdaran Ave., Tehran 16666
Iran

Purpose: To compare the efficacy and side effects of loteprednol versus fluorometholone after myopic photorefractive keratectomy (PRK). Methods: One hundred and twenty four eyes of 62 patients who underwent PRK were enrolled in this study. One eye of each subject was randomized to receive loteprednol 0.5% and the fellow eye was given fluorometholone 0.1%. Patients were followed up for three months. Results: There was no significant difference in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, corneal haze, intraocular pressure (IOP), and ocular discomfort and redness between groups at the final visit. At 3 months postoperatively, 20/25 or better UDVA was achieved in 95% of the loteprednol group and 92% of the fluorometholone group (P > 0.05). There was neither visually significant corneal haze nor ocular hypertension (IOP rise > 10 mmHg or IOP > 21 mmHg) in any group. Conclusion: The efficacy and side effects of loteprednol 0.5% and fluorometholone 0.1% after myopic PRK are comparable.


How to cite this article:
Karimian F, Faramarzi A, Fekri S, Mohammad-Rabie H, Najdi D, Doozandeh A, Delfaza-Baher S, Yaseri M. Comparison of loteprednol with fluorometholone after myopic photorefractive keratectomy.J Ophthalmic Vis Res 2017;12:11-16


How to cite this URL:
Karimian F, Faramarzi A, Fekri S, Mohammad-Rabie H, Najdi D, Doozandeh A, Delfaza-Baher S, Yaseri M. Comparison of loteprednol with fluorometholone after myopic photorefractive keratectomy. J Ophthalmic Vis Res [serial online] 2017 [cited 2017 Mar 28 ];12:11-16
Available from: http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=1;spage=11;epage=16;aulast=Karimian;type=0